Identification of novel non-pathogenic mutation in SH3 domain of Btk in an XLA patient.
A first report of an XLA patient with a polymorphism in Btk SH3 domain has been identified after sequencing of the entire gene. SH3 domain variants might not be detected due to well characterized mutations outside the domain.